We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Xtant Medical Hldgs Inc (XTNT) USD0.000001

Sell:$0.51 Buy:$0.58 Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
Change: No change
Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Xtant Medical Holdings, Inc. is a medical technology company, which is focused on the designing, development and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. The Company’s products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar and interbody spine. It promotes and sells its products in the United States through independent distributors and stocking agents. The Company also maintains a national accounts program to enable its agents to gain access to independent health delivery network hospitals and through group purchasing organizations (GPOs). Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, and its line of 3Demin products, as well as other allografts.

Contact details

664 Cruiser Ln
United States
+1 (406) 3880480

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
Market cap:
$47.15 million
Shares in issue:
87.31 million
Health Care Supplies
New York Stock Exchange
United States
US dollar

Key personnel

  • Jeffrey Peters
    Chairman of the Board
  • Sean Browne
    President, Chief Executive Officer, Director
  • Scott Neils
    Interim Chief Financial Officer
  • Kevin Brandt
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.


The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.